DaVita (DVA)
(Delayed Data from NYSE)
$163.14 USD
-0.02 (-0.01%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $163.16 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 18% (45 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.86 | 1.69 | 9.99 |
Current Quarter Estimate | 2.76 | 0.83 | 61.00 |
Year Ago Quarter Estimate | 2.85 | -0.88 | 54.84 |
Next Quarter Estimate | 2.21 | 0.84 | 63.00 |
Next Year Estimate | 11.42 | 6.13 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 17.95 | 16.90 | 15.67 |
Next Year | 14.31 | 14.50 | 11.34 |
Last 5 Years | 15.50 | 4.20 | 8.10 |
Next 5 Years | 17.50 | 12.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.84 | 18.10 |
Price/Book (MRQ) | 16.83 | 2.60 |
Price/Cash Flow (MRFY) | 9.71 | 15.09 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 6.86% | 3.16% |
Return on Equity (TTM) | 77.00% | 9.81% |
Debt to Equity (MRQ) | 9.94 | 30.21 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.